Clinical Updates in CSPC

 

Insights from 2023 ESMO Annual Meeting
E

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Patients With De Novo Metastatic Prostate Cancer - A Population-Based Analysis in New Hormonal Agents Era"

By Insights from 2023 ESMO Annual Meeting FEATURING Emre Yekedüz
By Insights from 2023 ESMO Annual Meeting FEATURING Emre Yekedüz
67 views
January 12, 2024
0 Comments
Login to view comments. Click here to Login
Clinical Updates in CSPC
11:07
PROSCA & BLADDR 2023

Treatment Intensification of High-Risk BCR Prostate Cancer

Feat. A. Rannikko
03:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Pati…

Feat. E. Yekedüz
09:02
Cedars Sinai

Year in Review: EMBARK Study and the Evolving Role of Intensified AD…

Feat. S. Freedland
09:51
Insights from 2023 Society of Urologic Oncology Annual Meeting

SUO 2023 Insights: "Doublets or Triplets for Patients With mCSP…

Feat. B. Maughan
09:19
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "De-Escalating Strategies in mHSPC - Who, W…

Feat. B. Tombal
05:29
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abir…

Feat. D. George
11:51
Joshua Lang

Therapeutic Approach in mCSPC: Doublets, Triplets, and Patient Selec…

08:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Minera…

Feat. A. Dalla Volta
13:55
Total Health

Case-Based Clinical Updates in Prostate Cancer: 77 y/o Practicing Ph…

Feat. J. Zhang, J. Chadha, S. Raymond
18:17
International Urology Cancer Summit - IUCS

Treatment Landscape of mHSPC: Doublet or Triplet

Feat. N. Agarwal
20:24
Scripps MD Anderson Cancer Center

Metastatic Newly Diagnosed Prostate Cancer: Up-Front Intensification…

Feat. T. Barauskas Dorff
11:37
Insights from 2023 ASCO® Annual Meeting

Assessment and Decision Tools for Balancing Survival and Quality of …

Feat. E. Kessler
04:55
Yale Cancer Center

Post-Hoc Analyses of Phase 3 ARCHES Trial: OS in Patients With mHSPC…

Feat. D. Petrylak
42:54
Houston Methodist Hospital

30 Years Perspective on Advanced Prostate Cancer: Using Biology &…

Feat. M. Hussain
12:48
ASCO GU 2023 Conference Coverage

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A …

Feat. M. Kohli
15:51
Judd Moul

A Multidisciplinary Team Approach to Prostate Cancer

11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
04:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide …

Feat. U. De Giorgi
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland